Kyle Keese is EVP & BioSciences Division at Emergent BioSolutions Inc. (EBS). They have made 3 open-market trades across 1 company since 2007, most recently 2011-03-15.
CIK 0001380186
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 3 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| EBS | 18,759 | $120K |
Shares reported on the most recent Form 4, priced at the 2011-03-17 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| EBS | SELL | 2010-08-18 | 2010-08-25 | $17.50 | $92K | -12.7% | -2.9% | -2.9% |
| EBS | SELL | 2008-11-11 | 2008-11-12 | $20.34 | $2K | -12.7% | -2.9% | -2.9% |
| EBS | SELL | 2008-11-11 | 2008-11-12 | $20.11 | $199K | -12.7% | -2.9% | -2.9% |
| EBS | SELL · 10b5-1 | 2007-06-28 | 2007-07-02 | $9.80 | $26K | -12.7% | -2.9% | -2.9% |
| EBS | SELL · 10b5-1 | 2007-06-26 | 2007-06-28 | $9.47 | $27K | -12.7% | -2.9% | -2.9% |
| EBS | SELL · 10b5-1 | 2007-06-22 | 2007-06-26 | $9.04 | $25K | -12.7% | -2.9% | -2.9% |
| EBS | SELL · 10b5-1 | 2007-06-20 | 2007-06-22 | $9.19 | $24K | -12.7% | -2.9% | -2.9% |
| EBS | SELL · 10b5-1 | 2007-06-18 | 2007-06-20 | $9.95 | $28K | -12.7% | -2.9% | -2.9% |
| EBS | SELL · 10b5-1 | 2007-06-14 | 2007-06-18 | $8.97 | $25K | -12.7% | -2.9% | -2.9% |
| EBS | SELL · 10b5-1 | 2007-06-12 | 2007-06-14 | $8.58 | $40K | -12.7% | -2.9% | -2.9% |
| EBS | SELL · 10b5-1 | 2007-06-08 | 2007-06-12 | $8.62 | $27K | -12.7% | -2.9% | -2.9% |
| EBS | SELL · 10b5-1 | 2007-06-06 | 2007-06-08 | $8.93 | $27K | -12.7% | -2.9% | -2.9% |
| EBS | SELL · 10b5-1 | 2007-06-04 | 2007-06-06 | $9.61 | $28K | -12.7% | -2.9% | -2.9% |
| EBS | SELL · 10b5-1 | 2007-05-31 | 2007-06-04 | $10.10 | $29K | -12.7% | -2.9% | -2.9% |
| EBS | SELL · 10b5-1 | 2007-05-29 | 2007-05-31 | $10.44 | $28K | -12.7% | -2.9% | -2.9% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.